# China Active Pharmaceutical Ingredient (API), farmaceutický medziprodukt, výrobca tetrazolu, dodávateľ, továreň - Run'an Pharmaceutical

> Run'an Pharmaceutical je skúsený výrobca a dodávateľ aktívnej farmaceutickej zložky (API), farmaceutického medziproduktu, tetrazolu a ďalších produktov. Spotrebiteľom môžeme rýchlo poskytnúť záruku kvality. Naša továreň ponúka vysoko kvalitné výrobky vyrobené v Číne s konkurenčnou cenou. Môžete zadať objednávku.

## Domov

- [Domov](https://sk.jsrapharm.com/)

## Bezpečnosť a ochrana životného prostredia

- [Bezpečnosť a ochrana životného prostredia](https://sk.jsrapharm.com/about.html)
- [Odoslať dopyt](https://sk.jsrapharm.com/message.html)
- [Kontaktuj nás](https://sk.jsrapharm.com/contact.html)

## Produkty

- [Produkty](https://sk.jsrapharm.com/products.html)
- [kategória produktu](https://sk.jsrapharm.com/product-category)
- [Aktívna farmaceutická zložka (API)](https://sk.jsrapharm.com/active-pharmaceutical-ingredient-api-)
- [Farmaceutický medziprodukt](https://sk.jsrapharm.com/pharmaceutical-intermediate)
- [tetrazol](https://sk.jsrapharm.com/tetrazole)
- [Iminazoly](https://sk.jsrapharm.com/iminazole)
- [Pyridín](https://sk.jsrapharm.com/pyridine)
- [Heterocykliká](https://sk.jsrapharm.com/heterocyclics)
- [Iguratimod](https://sk.jsrapharm.com/iguratimod)
- [Apremilast](https://sk.jsrapharm.com/apremilast)
- [Bromhexin HCl](https://sk.jsrapharm.com/bromhexine-hcl)
- [tofacitinib citrát](https://sk.jsrapharm.com/tofacitinib-citrate)
- [Urapidil hydrochlorid](https://sk.jsrapharm.com/urapidil-hydrochloride)
- [Garlicin](https://sk.jsrapharm.com/garlicin)
- [celekoxib](https://sk.jsrapharm.com/celecoxib)
- [Dexmedetomidín hydrochlorid](https://sk.jsrapharm.com/dexmedetomidine-hydrochloride)
- [Rokuróniumbromid](https://sk.jsrapharm.com/rocuronium-bromide)
- [Lifitegrast](https://sk.jsrapharm.com/lifitegrast)
- [Difelikefalin](https://sk.jsrapharm.com/difelikefalin)
- [gemcitabín HCl](https://sk.jsrapharm.com/gemcitabine-hcl)
- [Gemcitabín HCl T9](https://sk.jsrapharm.com/gemcitabine-hcl-t9)
- [Gemcitabín HCl T8](https://sk.jsrapharm.com/gemcitabine-hcl-t8)
- [Gemcitabín HCl T6](https://sk.jsrapharm.com/gemcitabine-hcl-t6)
- [Gemcitabín HCl T3](https://sk.jsrapharm.com/gemcitabine-hcl-t3)
- [1H-tetrazol](https://sk.jsrapharm.com/1h-tetrazole)
- [5-aminotetrazol](https://sk.jsrapharm.com/5-amino-tetrazole)
- [4,5-dikyanoimidazol](https://sk.jsrapharm.com/4-5-dicyanoimidazole)
- [2,6-diaminopyridín](https://sk.jsrapharm.com/2-6-diaminopyridine)
- [Kyselina 4-nitrobenzoová](https://sk.jsrapharm.com/4-nitrobenzoic-acid)
- [CAS č. 4418-61-5](https://sk.jsrapharm.com/cas-no-4418-61-5.html)
- [CAS 4418-61-5](https://sk.jsrapharm.com/cas-4418-61-5-1.html)
- [CAS#4418-61-5](https://sk.jsrapharm.com/cas-4418-61-5.html)
- [4418-61-5](https://sk.jsrapharm.com/4418-61-5.html)
- [CAS č. 288-94-8](https://sk.jsrapharm.com/cas-no-288-94-8.html)
- [CAS 288-94-8](https://sk.jsrapharm.com/cas-288-94-8-1.html)
- [CAS#288-94-8](https://sk.jsrapharm.com/cas-288-94-8.html)
- [288-94-8](https://sk.jsrapharm.com/288-94-8.html)
- [CAS č.141-86-6](https://sk.jsrapharm.com/cas-no-141-86-6.html)
- [CAS 141-86-6](https://sk.jsrapharm.com/cas-141-86-6-1.html)
- [CAS č. 141-86-6](https://sk.jsrapharm.com/cas-141-86-6.html)
- [141-86-6](https://sk.jsrapharm.com/141-86-6.html)
- [CAS č. 95058-92-7](https://sk.jsrapharm.com/cas-95058-92-7-1.html)
- [CAS č. 95058-92-7](https://sk.jsrapharm.com/cas-no-95058-92-7.html)
- [CAS 95058-92-7](https://sk.jsrapharm.com/cas-95058-92-7.html)
- [95058-92-7](https://sk.jsrapharm.com/95058-92-7.html)
- [Gemcitabín T3](https://sk.jsrapharm.com/gemcitabine-t3.html)
- [CAS č. 122111-01-7](https://sk.jsrapharm.com/cas-122111-01-7-1.html)
- [CAS č.122111-01-7](https://sk.jsrapharm.com/cas-no-122111-01-7.html)
- [CAS 122111-01-7](https://sk.jsrapharm.com/cas-122111-01-7.html)
- [122111-01-7](https://sk.jsrapharm.com/122111-01-7.html)
- [Gemcitabín T6](https://sk.jsrapharm.com/gemcitabine-t6.html)
- [CAS#122111-11-9](https://sk.jsrapharm.com/cas-122111-11-9-1.html)
- [CAS č. 122111-11-9](https://sk.jsrapharm.com/cas-no-122111-11-9.html)
- [CAS 122111-11-9](https://sk.jsrapharm.com/cas-122111-11-9.html)
- [122111-11-9](https://sk.jsrapharm.com/122111-11-9.html)
- [Gemcitabín T8](https://sk.jsrapharm.com/gemcitabine-t8.html)
- [CAS č. 134790-39-9](https://sk.jsrapharm.com/cas-134790-39-9-1.html)
- [CAS č. 134790-39-9](https://sk.jsrapharm.com/cas-no-134790-39-9.html)
- [CAS 134790-39-9](https://sk.jsrapharm.com/cas-134790-39-9.html)
- [134790-39-9](https://sk.jsrapharm.com/134790-39-9.html)
- [Gemcitabín T9](https://sk.jsrapharm.com/gemcitabine-t9.html)
- [CAS č. 1122-28-7](https://sk.jsrapharm.com/cas-no-1122-28-7.html)
- [CAS 1122-28-7](https://sk.jsrapharm.com/cas-1122-28-7-1.html)
- [CAS č. 1122-28-7](https://sk.jsrapharm.com/cas-1122-28-7.html)
- [1122-28-7](https://sk.jsrapharm.com/1122-28-7.html)
- [Imidazol-4,5-dikarbonitril](https://sk.jsrapharm.com/imidazole-4-5-dicarbonitrile.html)
- [4,5-dikyanoimidazol DCI](https://sk.jsrapharm.com/4-5-dicyanoimidazole-dci.html)
- [CAS Č.62-23-7](https://sk.jsrapharm.com/cas-no-62-23-7.html)
- [CAS 62-23-7](https://sk.jsrapharm.com/cas-62-23-7-1.html)
- [CAS č. 62-23-7](https://sk.jsrapharm.com/cas-62-23-7.html)
- [62-23-7](https://sk.jsrapharm.com/62-23-7.html)
- [CAS č. 119302-91-9](https://sk.jsrapharm.com/cas-119302-91-9-1.html)
- [CAS č. 119302-91-9](https://sk.jsrapharm.com/cas-no-119302-91-9.html)
- [CAS 119302-91-9](https://sk.jsrapharm.com/cas-119302-91-9.html)
- [119302-91-9](https://sk.jsrapharm.com/119302-91-9.html)
- [Rokurónium bromid API](https://sk.jsrapharm.com/rocuronium-bromide-api.html)
- [N-[[2-(6-Benzofuranylkarbonyl)-5,7-dichlór-1,2,3,4-tetrahydro-6-izochinolinyl]karbonyl]-3-(metylsulfonyl)-L-fenylalanín](https://sk.jsrapharm.com/n-2-6-benzofuranylcarbonyl-5-7-dichloro-1-2-3-4-tetrahydro-6-isoquinolinyl-carbonyl-3-methylsulfonyl-l-phenylalanine.html)
- [CAS č. 1025967-78-5](https://sk.jsrapharm.com/cas-1025967-78-5-1.html)
- [CAS č. 1025967-78-5](https://sk.jsrapharm.com/cas-no-1025967-78-5.html)
- [CAS 1025967-78-5](https://sk.jsrapharm.com/cas-1025967-78-5.html)
- [1025967-78-5](https://sk.jsrapharm.com/1025967-78-5.html)
- [Lifitegrast API](https://sk.jsrapharm.com/lifitegrast-api.html)
- [Kyselina 4-piperidínkarboxylová](https://sk.jsrapharm.com/4-piperidinecarboxylic-acid.html)
- [kyselina 1-(D-fenylalanyl-D-fenylalanyl-D-leucyl-D-lyzyl)-4-aminopiperidín-4-karboxylová](https://sk.jsrapharm.com/1-d-phenylalanyl-d-phenylalanyl-d-leucyl-d-lysyl-4-aminopiperidine-4-carboxylic-acid.html)
- [CAS č. 1024828-77-0](https://sk.jsrapharm.com/cas-1024828-77-0-1.html)
- [CAS č. 1024828-77-0](https://sk.jsrapharm.com/cas-no-1024828-77-0.html)
- [CAS 1024828-77-0](https://sk.jsrapharm.com/cas-1024828-77-0.html)
- [1024828-77-0](https://sk.jsrapharm.com/1024828-77-0.html)
- [Diallyltrisulfid](https://sk.jsrapharm.com/diallyl-trisulfide.html)
- [CAS#2050-87-5](https://sk.jsrapharm.com/cas-2050-87-5-1.html)
- [CAS č.2050-87-5](https://sk.jsrapharm.com/cas-no-2050-87-5.html)
- [CAS 2050-87-5](https://sk.jsrapharm.com/cas-2050-87-5.html)
- [2050-87-5](https://sk.jsrapharm.com/2050-87-5.html)
- [Cesnakový olej](https://sk.jsrapharm.com/garlicin-oil.html)
- [Protinádorový gemcitabín](https://sk.jsrapharm.com/anti-tumor-gemcitabine.html)
- [4-amino-1-[3,3-difluór-4-hydroxy-5-(hydroxymetyl)tetrahydrofurán-2-yl]-1h-pyrimidín-2-ón hydrochlorid](https://sk.jsrapharm.com/4-amino-1-3-3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydrofuran-2-yl-1h-pyrimidin-2-one-hydrochloride.html)
- [CAS č. 122111-03-9](https://sk.jsrapharm.com/cas-122111-03-9-1.html)
- [CAS Č. 122111-03-9](https://sk.jsrapharm.com/cas-no-122111-03-9.html)
- [CAS 122111-03-9](https://sk.jsrapharm.com/cas-122111-03-9.html)
- [122111-03-9](https://sk.jsrapharm.com/122111-03-9.html)
- [Gemcitabine Hydrochloride API](https://sk.jsrapharm.com/gemcitabine-hydrochloride-api.html)
- [Gemcitabine HCl API](https://sk.jsrapharm.com/gemcitabine-hcl-api.html)
- [Gemcitabín hydrochlorid](https://sk.jsrapharm.com/gemcitabine-hydrochloride.html)
- [CAS č. 169590-42-5](https://sk.jsrapharm.com/cas-169590-42-5-1.html)
- [CAS č. 540737-29-9](https://sk.jsrapharm.com/cas-540737-29-9-1.html)
- [CAS č. 64887-14-5](https://sk.jsrapharm.com/cas-64887-14-5-1.html)
- [CAS č. 611-75-6](https://sk.jsrapharm.com/cas-611-75-6-1.html)
- [CAS č. 608141-41-9](https://sk.jsrapharm.com/cas-608141-41-9-1.html)
- [CAS č. 123663-49-0](https://sk.jsrapharm.com/cas-123663-49-0-1.html)
- [4-[(1r)-1-(2,3-dimetylfenyl)etyl]-3h-imidazol hydrochlorid](https://sk.jsrapharm.com/4-1r-1-2-3-dimethylphenyl-ethyl-3h-imidazole-hydrochloride.html)
- [4-[(lr)-l-(2,3-dimetylfenyl)etyl]-3h-imidazol](https://sk.jsrapharm.com/4-1r-1-2-3-dimethylphenyl-ethyl-3h-imidazole.html)
- [CAS č. 145108-58-3](https://sk.jsrapharm.com/cas-145108-58-3-1.html)
- [CAS č. 145108-58-3](https://sk.jsrapharm.com/cas-no-145108-58-3.html)
- [CAS 145108-58-3](https://sk.jsrapharm.com/cas-145108-58-3.html)
- [145108-58-3](https://sk.jsrapharm.com/145108-58-3.html)
- [Dexmedetomidín HCl API](https://sk.jsrapharm.com/dexmedetomidine-hcl-api.html)
- [Dexmedetomidine Hydrochloride API](https://sk.jsrapharm.com/dexmedetomidine-hydrochloride-api.html)
- [Ostartritída Celecoxib](https://sk.jsrapharm.com/ostarthritis-celecoxib.html)
- [CAS č. 169590-42-5](https://sk.jsrapharm.com/cas-no-169590-42-5.html)
- [CAS 169590-42-5](https://sk.jsrapharm.com/cas-169590-42-5.html)
- [169590-42-5](https://sk.jsrapharm.com/169590-42-5.html)
- [Celecoxib API](https://sk.jsrapharm.com/celecoxib-api.html)
- [(3R,4R)-4-metyl-3-(metyl-7H-pyrolo[2,3-d]pyrimidín-4-ylamino)-b-oxo-1-piperidínpropánnitril: 2-Hydroxy-1,2,3- propántrikarboxylát](https://sk.jsrapharm.com/-3r-4r-4-methyl-3-methyl-7h-pyrrolo-2-3-d-pyrimidin-4-ylamino-b-oxo-1-piperidinepropanenitrile-2-hydroxy-1-2-3-propanetricarboxylate.html)
- [CAS č. 540737-29-9](https://sk.jsrapharm.com/cas-no-540737-29-9.html)
- [CAS 540737-29-9](https://sk.jsrapharm.com/cas-540737-29-9.html)
- [540737-29-9](https://sk.jsrapharm.com/540737-29-9.html)
- [Tofacitinib Citrate API](https://sk.jsrapharm.com/tofacitinib-citrate-api.html)
- [6-[[3-[4-(2-metoxyfenyl)-1-piperazinyl]propyl]amino]-1,3-dimetyl-2,4(1H,3H)-pyrimidíndión](https://sk.jsrapharm.com/6-3-4-2-methoxyphenyl-1-piperazinyl-propyl-amino-1-3-dimethyl-2-4-1h-3h-pyrimidinedione.html)
- [6-[[3-[4-(2-metoxyfenyl)-1-piperazinyl]propyl]amino]-1,3-dimetyl-2,4(1H,3H)-pyrimidíndión hydrochlorid](https://sk.jsrapharm.com/6-3-4-2-methoxyphenyl-1-piperazinyl-propyl-amino-1-3-dimethyl-2-4-1h-3h-pyrimidinedione-hydrochloride.html)
- [CAS č. 64887-14-5](https://sk.jsrapharm.com/cas-no-64887-14-5.html)
- [CAS 64887-14-5](https://sk.jsrapharm.com/cas-64887-14-5.html)
- [64887-14-5](https://sk.jsrapharm.com/64887-14-5.html)
- [Urapidil Hydrochlorid API](https://sk.jsrapharm.com/urapidil-hydrochloride-api.html)
- [2-amino-3,5-dibróm-N-cyklohexyl-N-metylbenzylamín hydrochlorid](https://sk.jsrapharm.com/2-amino-3-5-dibromo-n-cyclohexyl-n-methylbenzylamine-hydrochloride.html)
- [N- (2-amino-3,5-dibromobenzyl) -N-metylcyklohexylamín hydrochlorid](https://sk.jsrapharm.com/n-2-amino-3-5-dibromobenzyl-n-methylcyclohexylamine-hydrochloride.html)
- [CAS č.611-75-6](https://sk.jsrapharm.com/cas-no-611-75-6.html)
- [CAS 611-75-6](https://sk.jsrapharm.com/cas-611-75-6.html)
- [611-75-6](https://sk.jsrapharm.com/611-75-6.html)
- [API bromhexínu hydrochloridu](https://sk.jsrapharm.com/bromhexine-hydrochloride-api.html)
- [Brothxín HCI API](https://sk.jsrapharm.com/bromhexine-hcl-api.html)
- [CAS NO. 608141-41-9](https://sk.jsrapharm.com/cas-no-608141-41-9.html)
- [CAS 608141-41-9](https://sk.jsrapharm.com/cas-608141-41-9.html)
- [608141-41-9](https://sk.jsrapharm.com/608141-41-9.html)
- [Psoriasis plaquy aprmilast](https://sk.jsrapharm.com/plaque-psoriasis-apremilast.html)
- [(+)-n- ［2- ［1 (s)-(3-etoxy-4-metoxyfenyl) -2- (metylsulfonyl) etyl］ -1,3-dioxo-2,3-dihydro-1H-iSoindol-4-yl］ acetamid](https://sk.jsrapharm.com/-n-2-1-s-3-ethoxy-4-methoxyphenyl-2-methylsulfonyl-ethyl-1-3-dioxo-2-3-dihydro-1h-isoindol-4-yl-acetamide.html)
- [APRELAST API](https://sk.jsrapharm.com/apremilast-api.html)
- [Iguratimod](https://sk.jsrapharm.com/arthritis-iguratimod.html)
- [Reumatická artritída iguratimod](https://sk.jsrapharm.com/rheumatic-arthritis-iguratimod.html)
- [CAS č.123663-49-0](https://sk.jsrapharm.com/cas-no-123663-49-0.html)
- [CAS 123663-49-0](https://sk.jsrapharm.com/cas-123663-49-0.html)
- [123663-49-0](https://sk.jsrapharm.com/123663-49-0.html)
- [N-(3-Formamido-4-oxo-6-fenoxy-4H-chromen-7-yl)metánsulfónamid N-[7-(metánsulfónamido)-4-oxo-6-fenoxy-4H-chromen-3-yl]formamid](https://sk.jsrapharm.com/n-3-formamido-4-oxo-6-phenoxy-4h-chromen-7-yl-methanesulfonamide-n-7-methanesulfonamido-4-oxo-6-phenoxy-4h-chromen-3-yl-formamide.html)
- [Iguramatimod API](https://sk.jsrapharm.com/iguratimod-api.html)

## Správy

- [Správy](https://sk.jsrapharm.com/news.html)
- [Blog](https://sk.jsrapharm.com/news/blog)
- [Novinky spoločnosti](https://sk.jsrapharm.com/news-69.html)
- [Správy z priemyslu](https://sk.jsrapharm.com/news-70.html)
- [2023 CPHI Barcelona](https://sk.jsrapharm.com/news-show-579.html)
- [Zhromaždite sa pri novej kapitole](https://sk.jsrapharm.com/news-show-580.html)
- [Zhromaždite silu, pokračujte vpred | Výročné stretnutie a stretnutie s pochvalami Jiangsu Runan Pharmaceutical Co., LTD](https://sk.jsrapharm.com/news-show-581.html)
- [2024 CPHI Japonsko](https://sk.jsrapharm.com/news-show-582.html)
- [Špeciálny praktický nácvik nehôd s únikom plynu na oddelení logistiky spoločnosti v roku 2024](https://sk.jsrapharm.com/news-show-583.html)
- [Výstava API 2023](https://sk.jsrapharm.com/news-show-584.html)
- [Vystúpenie na konferencii o výmene pokročilých skúseností spoločnosti Jiangsu Runan Pharmaceutical o bezpečnej výrobe podnikov v priemyselných parkoch](https://sk.jsrapharm.com/news-show-585.html)
- [Komplexné praktické školenie pre bezpečnostné nehody vo výrobe v roku 2023](https://sk.jsrapharm.com/news-show-586.html)
- [Oznámenie o schválení klinických skúšok inovatívnych liekov 1. triedy od Jiangsu Zhengda Qingjiang Pharmaceutical Co., Ltd](https://sk.jsrapharm.com/news-show-587.html)
- [Jiangsu Run'an Pharmaceutical Co., Ltd. Bezpečná výroba Mesiac Súhrn činnosti, hodnotenie, oznámenie o odmene a pochvale](https://sk.jsrapharm.com/news-show-588.html)
- [Jiangsu Runan Pharmaceutical víta inšpekciu GMP](https://sk.jsrapharm.com/news-show-589.html)
- [Posilniť ochranu duševného vlastníctva a vytvoriť inovatívnu vysočinu](https://sk.jsrapharm.com/news-show-590.html)
- [Chen Zhichang, tajomník mestského straníckeho výboru, vykonal výskum výstavby novej výrobnej oblasti Zhengda Qingjiang Pharmaceutical](https://sk.jsrapharm.com/news-show-591.html)
- [Oznámenie spoločnosti Jiangsu Run'an Pharmaceutical Co., Ltd. pred auditom čistej výroby v roku 2023](https://sk.jsrapharm.com/news-show-592.html)
- [Nitroprusid sodný a urapidil, obe antihypertenzíva, majú rôzne kontraindikácie a nežiaduce účinky!](https://sk.jsrapharm.com/news-show-593.html)
- [Farmakologická charakteristika dexmedetomidínu a jeho aplikácia pri pooperačnom delíriu u starších pacientov](https://sk.jsrapharm.com/news-show-594.html)
- [Kto je účinnejší, Elamod alebo Metotrexát](https://sk.jsrapharm.com/news-show-595.html)
- [Lifitegrast](https://sk.jsrapharm.com/news-show-919.html)
- [2024 CPHI CHINA Šanghaj](https://sk.jsrapharm.com/news-show-920.html)
- [Difelikefalin – prvý liek schválený FDA na liečbu svrbenia súvisiaceho s chronickým ochorením obličiek (CKD) – injekcia Difelikefalinu](https://sk.jsrapharm.com/news-show-1529.html)
- [Je to 5-aminotetrazol](https://sk.jsrapharm.com/news/is-5-amino-tetrazole-87129.html)
- [Aké sú vlastnosti 1H-tetrazolu?](https://sk.jsrapharm.com/news-show-1531.html)
- [Aké sú vedľajšie účinky užívania 2,6-diaminopyridínu?](https://sk.jsrapharm.com/news-show-1532.html)
- [Aké sú náklady na Gemcitabine HCl T3 a je krytý poistením?](https://sk.jsrapharm.com/news-show-1533.html)
- [Sú dostupné nejaké klinické štúdie pre Gemcitabine HCl T6?](https://sk.jsrapharm.com/news-show-1534.html)
- [Ako sa gemcitabín HCl T8 podáva pacientom?](https://sk.jsrapharm.com/news/how-is-gemcitabine-hcl-t8-administered-to-patients--57448.html)
- [Existujú nejaké alternatívne spôsoby liečby gemcitabínu HCl T9 pre pacientov s rakovinou?](https://sk.jsrapharm.com/news-show-1536.html)
- [Aké sú použitia 4,5-dikyanoimidazolu?](https://sk.jsrapharm.com/news-show-1537.html)
- [Čo je kyselina 4-nitrobenzoová a jej použitie?](https://sk.jsrapharm.com/news/what-is-4-nitrobenzoic-acid-and-its-uses--78146.html)
- [Čo je urapidil hydrochlorid](https://sk.jsrapharm.com/news/what-is-urapidil-hydrochloride-42624.html)
- [Ako dexmedetomidín hydrochlorid ovplyvňuje kardiovaskulárny systém?](https://sk.jsrapharm.com/news-show-1540.html)
- [Aké sú vedľajšie účinky Rocuronium bromidu?](https://sk.jsrapharm.com/news-show-1541.html)
- [Aké sú vedľajšie účinky](https://sk.jsrapharm.com/news/what-are-the-side-effects-41262.html)
- [Aké je odporúčané dávkovanie](https://sk.jsrapharm.com/news-show-1543.html)
- [Aké sú najlepšie spôsoby začlenenia Garlicínu](https://sk.jsrapharm.com/news-show-1544.html)
- [Výhody Tetrazolu](https://sk.jsrapharm.com/news-show-1545.html)
- [2024 API XI'an](https://sk.jsrapharm.com/news-show-1970.html)
- [Prečo je kyselina 4-nitrobenzoová silnejšia kyselina ako kyselina benzoová?](https://sk.jsrapharm.com/news-show-1971.html)
- [Prečo je 2,6-diaminopyridín základnou zlúčeninou v chemickej syntéze?](https://sk.jsrapharm.com/news-show-1973.html)
- [Čo sú heterocyklické zlúčeniny a prečo sú dôležité?](https://sk.jsrapharm.com/news-show-1974.html)
- [Koľko vieš o heterocyklických?](https://sk.jsrapharm.com/news-show-1975.html)
- [Ako sa používa kyselina 4-nitrobenzoová v priemyselných a farmaceutických aplikáciách?](https://sk.jsrapharm.com/news-show-2168.html)
- [Aká je funkcia pyridínu?](https://sk.jsrapharm.com/news-show-2169.html)
- [Na čo by sa malo venovať pozornosť pri používaní 2,6-diaminopyridínu?](https://sk.jsrapharm.com/news-show-2170.html)
- [Ako môže pyridín zefektívniť vašu výrobu vo farmaceutikách a jemných chemikáliách?](https://sk.jsrapharm.com/news-show-2171.html)
- [Čo je imidazol?](https://sk.jsrapharm.com/news-show-2751.html)
- [Aké sú oblasti aplikácií imidazolu?](https://sk.jsrapharm.com/news-show-2760.html)
- [Aké sú dnes hlavné priemyselné použitie pyridínu?](https://sk.jsrapharm.com/news-show-2766.html)
- [Kde sa používa hlavne tetrazol?](https://sk.jsrapharm.com/news-show-2773.html)
- [Poznáte Diallyl Trisulfide?](https://sk.jsrapharm.com/news-show-2783.html)
- [Existujú nejaké vedľajšie účinky gemcitabínu HCl T9?](https://sk.jsrapharm.com/news-show-2786.html)
- [Aká nenahraditeľná hodnota má CAS 141-86-6?](https://sk.jsrapharm.com/news-show-2792.html)
- [Prečo prísady DCI získavajú popularitu medzi výrobcami batérií?](https://sk.jsrapharm.com/news-show-2802.html)
- [Na čo sa používa imidazol-4,5-dikarbonitril?](https://sk.jsrapharm.com/news-show-2810.html)
- [Je pyridín známy karcinogén?](https://sk.jsrapharm.com/news-show-2817.html)
- [Gemcitabín T3: liek, ktorý vykazuje presný zacieľovací potenciál v oblasti liečby nádorom](https://sk.jsrapharm.com/news-show-2822.html)
- [Použitie citrátu tofacitinib a mechanizmus pôsobenia](https://sk.jsrapharm.com/news-show-2824.html)
- [Prečo zvoliť kyselinu 4-nitrobenzoovú](https://sk.jsrapharm.com/news-show-2827.html)
- [Nedávny pokrok v klinických aplikáciách dexmedetomidínového hydrochloridu](https://sk.jsrapharm.com/news-show-2984.html)
- [Môže iguratimod artritídy skutočne zmeniť výhľad u pacientov s chronickou artritídou?](https://sk.jsrapharm.com/news-show-2988.html)
- [Čo robí APREMILAST API spoľahlivou voľbou vo farmaceutickej výrobe?](https://sk.jsrapharm.com/news-show-3044.html)
- [Čo robí CAS č. 611-75-6 nevyhnutnými v moderných farmaceutických aplikáciách?](https://sk.jsrapharm.com/news-show-3094.html)
- [Čo robí tofacitinib citrát spoľahlivou farmaceutickou možnosťou?](https://sk.jsrapharm.com/news-show-3138.html)
- [Prečo zvoliť dexmedetomidín hydrochlorid pre klinické a farmaceutické aplikácie?](https://sk.jsrapharm.com/news-show-3269.html)
- [Prečo sa Dalcell trisulfid považuje za silnú bioaktívnu zlúčeninu?](https://sk.jsrapharm.com/news-show-3281.html)
- [Prečo by ste si mali zvoliť kyselinu 4-nitrobenzoovú pre svoje priemyselné a farmaceutické potreby?](https://sk.jsrapharm.com/news-show-3292.html)
- [Čo robí CAS č. 540737-29-9 nevyhnutným medziproduktom vo farmaceutickej syntéze?](https://sk.jsrapharm.com/news-show-3345.html)
- [Prečo je CAS 64887-14-5 taký dôležitý v moderných farmaceutických aplikáciách?](https://sk.jsrapharm.com/news-show-3394.html)
- [Čo je CAS NO. 288-94-8 a prečo by ste to mali zvážiť?](https://sk.jsrapharm.com/news-show-3481.html)
- [Prečo sa diallyltrisulfid stáva esenciálnou zlúčeninou v moderných chemických aplikáciách?](https://sk.jsrapharm.com/news-show-3491.html)
- [Ako ovplyvňuje 1H-tetrazol farmaceutické aplikácie?](https://sk.jsrapharm.com/news-show-3544.html)
- [Rocuronium Bromide API: Ako jediná molekula podporuje celkovú anestéziu na celom svete?](https://sk.jsrapharm.com/news/rocuronium-bromide-api-how-does-a-single-molecule-support-general-anesthesia-worldwide.html)
- [Ako môže Iguratimod zmeniť manažment reumatických chorôb?](https://sk.jsrapharm.com/news/how-can-iguratimod-transform-the-management-of-rheumatic-diseases.html)

## Language

- [Español](https://es.jsrapharm.com/)
- [Português](https://pt.jsrapharm.com/)
- [русский](https://ru.jsrapharm.com/)
- [Français](https://fr.jsrapharm.com/)
- [日本語](https://ja.jsrapharm.com/)
- [Deutsch](https://de.jsrapharm.com/)
- [tiếng Việt](https://vi.jsrapharm.com/)
- [Italiano](https://it.jsrapharm.com/)
- [Nederlands](https://nl.jsrapharm.com/)
- [ภาษาไทย](https://th.jsrapharm.com/)
- [Polski](https://pl.jsrapharm.com/)
- [한국어](https://ko.jsrapharm.com/)
- [Svenska](https://sv.jsrapharm.com/)
- [magyar](https://hu.jsrapharm.com/)
- [Malay](https://ms.jsrapharm.com/)
- [বাংলা ভাষার](https://bn.jsrapharm.com/)
- [Dansk](https://da.jsrapharm.com/)
- [Suomi](https://fi.jsrapharm.com/)
- [हिन्दी](https://hi.jsrapharm.com/)
- [Pilipino](https://tl.jsrapharm.com/)
- [Türkçe](https://tr.jsrapharm.com/)
- [Gaeilge](https://ga.jsrapharm.com/)
- [العربية](https://ar.jsrapharm.com/)
- [Indonesia](https://id.jsrapharm.com/)
- [Norsk‎](https://no.jsrapharm.com/)
- [تمل](https://ur.jsrapharm.com/)
- [český](https://cs.jsrapharm.com/)
- [ελληνικά](https://el.jsrapharm.com/)
- [український](https://uk.jsrapharm.com/)
- [Javanese](https://jw.jsrapharm.com/)
- [فارسی](https://fa.jsrapharm.com/)
- [தமிழ்](https://ta.jsrapharm.com/)
- [తెలుగు](https://te.jsrapharm.com/)
- [नेपाली](https://ne.jsrapharm.com/)
- [Burmese](https://my.jsrapharm.com/)
- [български](https://bg.jsrapharm.com/)
- [ລາວ](https://lo.jsrapharm.com/)
- [Latine](https://la.jsrapharm.com/)
- [Қазақша](https://kk.jsrapharm.com/)
- [Euskal](https://eu.jsrapharm.com/)
- [Azərbaycan](https://az.jsrapharm.com/)
- [Slovenský jazyk](https://sk.jsrapharm.com/)
- [Македонски](https://mk.jsrapharm.com/)
- [Lietuvos](https://lt.jsrapharm.com/)
- [Eesti Keel](https://et.jsrapharm.com/)
- [Română](https://ro.jsrapharm.com/)
- [Slovenski](https://sl.jsrapharm.com/)
- [मराठी](https://mr.jsrapharm.com/)
- [Srpski језик](https://sr.jsrapharm.com/)